August 21, 2019 / 5:09 AM / a month ago

BRIEF-Zur Rose Group H1 Net Loss Of CHF 17.1 Mln

Aug 21 (Reuters) - Zur Rose Group Ag:

* TARGETS FOR 2022 CONFIRMED

* INCLUDING MEDPEX SALES, H1 GROUP REVENUE WAS UP 28.1 PER CENT TO CHF 771.8 MILLION YEAR ON YEAR

* H1 EBITDA MARGIN IMPROVED FROM MINUS 1.5 PER CENT TO MINUS 0.4 PER CENT

* INCLUDING ALL EXCEPTIONAL ITEMS, H1 EBITDA IMPROVED FROM MINUS CHF 9.0 MILLION TO MINUS CHF 2.5 MILLION

* H1 NET INCOME / (LOSS) OF MINUS CHF 17.1 MILLION WAS INCURRED (PREVIOUS YEAR: MINUS CHF 17.6 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below